These are the 25 stocks to bet against on a successful COVID-19 vaccine, according to JPMorgan

Advertisement
These are the 25 stocks to bet against on a successful COVID-19 vaccine, according to JPMorgan
Drew Angerer/Getty Images
  • With a successful COVID-19 vaccine on the horizon, some stocks may fare better than others.
  • According to JPMorgan, investors should look to bet against a handful of stocks that have experienced increased momentum in their business amid the COVID-19 pandemic.
  • Once a successful COVID vaccine is distributed and administered, it could lead to a slowdown in growth for a number of businesses as a return to normal activity ensues.
  • Here are 25 stocks traders should bet against once a successful COVID-19 vaccine is disbursed, according to JPMorgan.
  • Visit Business Insider's homepage for more stories.
Advertisement

The development of a successful COVID-19 vaccine could have wide-ranging implications on a basket of stocks that saw a surge in growth amid the pandemic.

That's according to a Friday note from JPMorgan, which put together a list of 25 stocks traders should bet against once a COVID-19 vaccine is distributed and administered to the population.

"This is a list of stocks that are in the upper echelon of Momentum and have crowded positioning, that could see the second derivative of their profit growth decrease as consumer/corporate activity normalizes," JPMorgan explained.

On the flip side, Goldman Sachs offered six stocks on Friday that could benefit from the distribution and administration of a successful COVID-19 vaccine.

The JPMorgan basket of stocks should be viewed as a tactical opportunity to express a bearish view on the catalyst of a COVID-19 vaccine, and should not be viewed as a fundamental call on the company.

Advertisement

Here are 25 stocks traders should bet against once a successful COVID-19 vaccine is disbursed, according to JPMorgan.

Read more: Don't put too much energy into predicting the result -- 5 key tips for clients from strategists at JPMorgan's $1.9 trillion asset management arm with less than two weeks to go to the election

1. Novavax

YTD Performance: 2190%

2. Zoom Video

Advertisement

YTD Performance: 654%

3. Overstock.com

YTD Performance: 887%

4. Fiverr International

YTD Performance: 583%

Advertisement

5. Peloton Interactive

YTD Performance: 338%

6. Moderna

YTD Performance: 250%

7. Stamps.com

Advertisement

YTD Performance: 206%

8. Wayfair

YTD Performance: 199%

9. Vista Outdoor

YTD Performance: 171%

Advertisement

10. Bandwith

YTD Performance: 167%

Read More: MORGAN STANLEY: Buy these 61 stocks that will offer major earnings-driven upside following an imminent 10% market sell-off

11. Boston Beer Company

YTD Performance: 141%

Advertisement

12. Chegg.com

YTD Performance: 127%

13. Logitech International

YTD Performance: 95%

14. Big Lots

Advertisement

YTD Performance: 81%

15. Grubhub

YTD Performance: 66%

16. Chipotle Mexican Grill

YTD Performance: 63%

Advertisement

17. Yeti Holdings

YTD Performance: 47%

18. Scotts Miracle-Gro

YTD Performance: 47%

19. K12

Advertisement

YTD Performance: 40%

Read More: Big investors pay thousands of dollars for Danielle DiMartino Booth's research. The former Fed advisor explains how the central bank has distorted markets - and shares 2 areas where analytical traders can still find returns.

20. Equinix

YTD Performance: 38%

21. Clorox

Advertisement

YTD Performance: 38%

22. Costco Wholesale

YTD Performance: 29%

23. Digital Realty Trust

YTD Performance: 29%

Advertisement

24. Central Garden & Pet

YTD Performance: 26%

25. American Well

Performance since IPO: 25%

These are the 25 stocks to bet against on a successful COVID-19 vaccine, according to JPMorgan
JPMorgan
{{}}